Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI

Study Title
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
Teva Identifier
ABS-AS-101
ClinicalTrials.gov Identifier
NCT01056159
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol dry powder inhaler | Drug: Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 45 Years
Trial Duration
01/01/2010 - 06/01/2010
Phase
Phase 1

Study Type

Interventional